Abingdon Health partners with Crest Medical to launch Boots’ own-brand rapid self-tests

Abingdon Health plc (AIM: ABDX), a pioneering Contract Development and Manufacturing Organisation (CDMO) specializing in lateral flow tests, has announced a strategic collaboration with Crest Medical, leading to the launch of Boots’ own-brand rapid self-tests for Iron and Vitamin D deficiencies in the UK. Scheduled for release in Spring 2024, these tests will be available both in Boots stores nationwide and online at Boots.com, marking a significant advancement in the consumer lateral flow self-test market.

As part of this collaboration, Abingdon Health positions itself as a key player in the rapidly expanding lateral flow assay market, which is projected to reach USD $23 billion by 2027. The introduction of Iron and Vitamin D deficiency tests under the trusted Boots brand aims to bolster consumer confidence in at-home testing solutions, reflecting a growing trend towards self-diagnostic tools in healthcare.

This launch is a testament to Abingdon Health’s expertise in developing and manufacturing high-quality lateral flow tests, as well as its ability to serve as an Original Equipment Manufacturer (OEM) for branded self-tests across the UK and Europe. By offering a comprehensive private label service, Abingdon Health caters to a broad spectrum of consumer health needs, from deficiency tests to innovative products developed by its CDMO customers.

Chris Yates, CEO of Abingdon Health, expressed enthusiasm about the partnership and the launch, highlighting the company’s commitment to quality and its role in expanding access to reliable self-testing options for consumers. “We take immense pride in the quality of our service and ensure a seamless supply of innovative lateral flow self-tests to meet our partners’ requirements,” Yates stated.

Matthew Courtney, CEO of Crest Medical, also emphasized the significance of adding diagnostic tests to their portfolio and deepening their relationship with Boots. “Abingdon Health are at the forefront of this expansion, and we are thrilled to be partnering with a company who are leaders in lateral flow diagnostics,” Courtney remarked.

The strategic partnership between Abingdon Health, Crest Medical, and Boots represents a major milestone in the consumer health diagnostics sector, demonstrating the potential of lateral flow tests to revolutionize at-home healthcare. By leveraging the strength of the Boots brand, this initiative is set to enhance consumer access to health diagnostics, encouraging proactive health management and contributing to the broader adoption of self-testing solutions.